Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/44777
Title: Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritis
Authors: VANDORMAEL, Patrick 
FADLALLAH, sukayna 
RUYTINX, Pieter 
PUES, Astrid 
SLEURS, Ellen 
LIESENBORGS, Jori 
Joly, Johan
AGTEN, Anouk 
VANDENABEELE, Frank 
FRAUSSEN, Judith 
Verschueren, Patrick
SOMERS, Veerle 
Issue Date: 2024
Publisher: 
Source: RMD open, 10 (4) (Art N° e004743)
Abstract: To discover antibody biomarkers that can predict a lack of response to first-line therapy in rheumatoid arthritis (RA) patients.
Keywords: Therapeutics;Arthritis, Rheumatoid;Antibodies;Autoimmune Diseases
Document URI: http://hdl.handle.net/1942/44777
ISSN: 2056-5933
e-ISSN: 2056-5933
DOI: 10.1136/rmdopen-2024-004743
ISI #: 001356630200001
Rights: Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early .pdfPublished version1.2 MBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.